Literature DB >> 27159789

Atrial fibrillation.

Gregory Y H Lip1,2, Laurent Fauchier3, Saul B Freedman4, Isabelle Van Gelder5, Andrea Natale6, Carola Gianni6, Stanley Nattel7,8, Tatjana Potpara9, Michiel Rienstra10, Hung-Fat Tse11, Deirdre A Lane1.   

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, and increases in prevalence with increasing age and the number of cardiovascular comorbidities. AF is characterized by a rapid and irregular heartbeat that can be asymptomatic or lead to symptoms such as palpitations, dyspnoea and dizziness. The condition can also be associated with serious complications, including an increased risk of stroke. Important recent developments in the clinical epidemiology and management of AF have informed our approach to this arrhythmia. This Primer provides a comprehensive overview of AF, including its epidemiology, mechanisms and pathophysiology, diagnosis, screening, prevention and management. Management strategies, including stroke prevention, rate control and rhythm control, are considered. We also address quality of life issues and provide an outlook on future developments and ongoing clinical trials in managing this common arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27159789     DOI: 10.1038/nrdp.2016.16

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  55 in total

1.  Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Authors:  A Mantovani; R Rigolon; A Civettini; B Bolzan; G Morani; S Bonapace; C Dugo; G Zoppini; E Bonora; G Targher
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

2.  Catheter ablation did not reduce CV events and mortality more than drug therapy in symptomatic AF.

Authors:  Gaetano Santulli
Journal:  Ann Intern Med       Date:  2019-07-16       Impact factor: 25.391

3.  Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?

Authors:  Farhan Shahid; Gregory Y H Lip
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

4.  Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction.

Authors:  Ahsan A Khan; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2017-12

Review 5.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

6.  Scale-invariant structures of spiral waves.

Authors:  Daniel Sohn; Konstantinos Aronis; Hiroshi Ashikaga
Journal:  Comput Biol Med       Date:  2018-11-14       Impact factor: 4.589

7.  Recurrence of Atrial Fibrillation in Dependence of Left Atrial Volume Index.

Authors:  Malte Kranert; Tetyana Shchetynska-Marinova; Volker Liebe; Christina Doesch; Theano Papavassiliu; Ibrahim Akin; Martin Borggrefe; Anna Hohneck
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

8.  AF Classification from a Short Single Lead ECG Recording: the PhysioNet/Computing in Cardiology Challenge 2017.

Authors:  Gari D Clifford; Chengyu Liu; Benjamin Moody; Li-Wei H Lehman; Ikaro Silva; Qiao Li; A E Johnson; Roger G Mark
Journal:  Comput Cardiol (2010)       Date:  2018-04-05

9.  ECG signal classification for the detection of cardiac arrhythmias using a convolutional recurrent neural network.

Authors:  Zhaohan Xiong; Martyn P Nash; Elizabeth Cheng; Vadim V Fedorov; Martin K Stiles; Jichao Zhao
Journal:  Physiol Meas       Date:  2018-09-24       Impact factor: 2.833

10.  Multiscale network dynamics between heart rate and locomotor activity are altered in schizophrenia.

Authors:  Erik Reinertsen; Supreeth P Shashikumar; Amit J Shah; Shamim Nemati; Gari D Clifford
Journal:  Physiol Meas       Date:  2018-10-30       Impact factor: 2.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.